Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.725
EU - Europa 5.275
AS - Asia 2.691
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 18
AF - Africa 13
Totale 17.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.540
IT - Italia 1.060
DE - Germania 999
CN - Cina 998
SG - Singapore 880
SE - Svezia 814
IE - Irlanda 693
UA - Ucraina 463
RU - Federazione Russa 439
HK - Hong Kong 289
GB - Regno Unito 277
CA - Canada 180
VN - Vietnam 150
FI - Finlandia 118
AT - Austria 107
IN - India 87
FR - Francia 85
DK - Danimarca 83
KR - Corea 73
ID - Indonesia 58
JP - Giappone 53
TR - Turchia 50
BE - Belgio 37
NL - Olanda 32
PL - Polonia 22
EU - Europa 18
IR - Iran 18
TW - Taiwan 15
NZ - Nuova Zelanda 14
AU - Australia 12
EG - Egitto 10
BR - Brasile 8
ES - Italia 8
BG - Bulgaria 7
IL - Israele 6
PE - Perù 6
RO - Romania 6
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HR - Croazia 3
IQ - Iraq 3
MX - Messico 3
RS - Serbia 3
CL - Cile 2
CO - Colombia 2
GT - Guatemala 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
SC - Seychelles 2
BD - Bangladesh 1
EE - Estonia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 17.766
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.831
Singapore 710
Dublin 674
Chandler 666
Woodbridge 649
Frankfurt am Main 608
Wilmington 532
Jacksonville 458
Dearborn 453
Milan 420
Houston 409
Fairfield 405
Ashburn 322
New York 312
Princeton 271
Hong Kong 251
Nanjing 196
Seattle 177
Boardman 165
Santa Clara 145
Shanghai 133
Cambridge 123
Vienna 100
Beijing 79
Dong Ket 74
Lachine 74
Guangzhou 71
Lawrence 67
Nanchang 67
Altamura 61
Jakarta 57
Shenyang 53
Andover 49
Fremont 43
Jinan 40
Toronto 38
Pune 36
Helsinki 34
Ottawa 34
San Diego 34
Chicago 32
Falls Church 32
Tianjin 31
Brussels 30
Hangzhou 30
Los Angeles 27
Rome 27
Daejeon 26
Melzo 26
Zhengzhou 26
Changsha 25
Jiaxing 25
Kunming 25
London 23
Nürnberg 23
Grafing 21
Norwalk 21
Sacramento 21
Hebei 20
Shangdi 20
Bergamo 19
Dallas 19
Mountain View 17
Edmonton 16
Tokyo 16
Kocaeli 15
Leawood 15
Ningbo 15
Carate Brianza 14
Hefei 14
Kiev 14
Lissone 14
Phoenix 13
Codroipo 12
Shinjuku 12
Kraków 11
Seoul 11
Florence 10
Taizhou 10
Washington 10
Cagliari 9
Mainz 9
Bologna 8
Buffalo 8
Wuhan 8
Canazei 7
Changchun 7
Chengdu 7
Lappeenranta 7
Monza 7
San Mateo 7
Sesto San Giovanni 7
Yongin-si 7
Boston 6
Fuzhou 6
Huizen 6
Laurel 6
Paris 6
Pavia 6
Somma Lombardo 6
Totale 12.849
Salva come PNG Salva come JPEG
Nome #
Age-related changes in the function and structure of the peripheral sensory pathway in mice 292
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 292
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 288
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 284
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 273
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 239
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 233
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 230
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 224
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 212
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 204
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 202
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 202
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 200
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 199
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 194
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 194
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 192
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 191
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 189
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 187
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 181
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 180
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 180
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 179
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 177
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 175
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 175
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 172
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 172
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 170
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 169
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 168
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 165
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 165
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 164
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 164
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 163
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 163
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 155
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 153
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 153
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 149
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 148
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 147
Granulocytes in actively induced Lewis rat EAE 146
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 146
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 146
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 144
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 144
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 138
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 136
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 135
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 133
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 132
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 131
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 131
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 128
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 128
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 128
Multimodal experimental approach to the study of human neurological diseases 126
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 126
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 125
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 125
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 124
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 124
MSCs effect on Dark Agouti rats affected by chronic EAE 123
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 123
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 123
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 123
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 123
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 122
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 122
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 122
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 120
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 120
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 120
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 117
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 115
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 114
Pharmacokinetics of IVIg in Wistar rats 112
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 112
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 112
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 111
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 111
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 107
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 106
Caratterizzazione dell'effetto analgesico di un nuovo ligando del recettore I2 imidazolinico in un modello animale di dolore neuropatico indotto da bortezomib 105
Methylene blue protects against paclitaxel-induced peripheral neurotoxicity 104
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 104
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice 103
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 101
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 98
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 98
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 97
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 96
Aging Action on Peripheral Nervous System in C57bl/6 Mice: a Morphological and Morphometric Study 95
“Metabolic pathways in clear cell renal cell carcinoma: possible therapeutic targets 95
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 94
Totale 15.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.398 0 0 197 164 269 362 486 178 247 254 199 42
2020/20213.099 128 88 317 297 247 275 334 313 292 261 220 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.991 376 737 335 270 222 486 42 144 223 43 76 37
2023/20242.525 83 65 69 89 329 590 408 114 140 51 44 543
2024/20251.906 419 843 644 0 0 0 0 0 0 0 0 0
Totale 19.025